{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T10:29:34Z","timestamp":1782210574313,"version":"3.54.5"},"reference-count":15,"publisher":"Japanese Society of Internal Medicine","issue":"13","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2017]]},"DOI":"10.2169\/internalmedicine.56.8313","type":"journal-article","created":{"date-parts":[[2017,6,30]],"date-time":"2017-06-30T22:09:59Z","timestamp":1498860599000},"page":"1687-1690","source":"Crossref","is-referenced-by-count":13,"title":["Acute Kidney Injury from Excessive Potentiation of Calcium-channel Blocker via Synergistic CYP3A4 Inhibition by Clarithromycin Plus Voriconazole"],"prefix":"10.2169","volume":"56","author":[{"given":"Eikan","family":"Mishima","sequence":"first","affiliation":[{"name":"Division of Nephrology, Endocrinology, and Vascular Medicine, Tohoku University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuichi","family":"Maruyama","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Tohoku University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Nakazawa","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Tohoku University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takaaki","family":"Abe","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Endocrinology, and Vascular Medicine, Tohoku University Graduate School of Medicine, Japan"},{"name":"Division of Medical Science, Tohoku University Graduate School of Biomedical Engineering, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadayoshi","family":"Ito","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Endocrinology, and Vascular Medicine, Tohoku University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","unstructured":"1. Bailey DG, Bend JR, Arnold JM, Tran LT, Spence JD. Erythromycin-felodipine interaction: magnitude, mechanism, and comparison with grapefruit juice. Clin Pharmacol Ther 60: 25-33, 1996."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Wright AJ, Gomes T, Mamdani MM, Horn JR, Juurlink DN. The risk of hypotension following co-prescription of macrolide antibiotics and calcium-channel blockers. CMAJ 183: 303-307, 2011.","DOI":"10.1503\/cmaj.100702"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Tsuruta S, Nakamura K, Arimori K, Nakano M. Effects of erythromycin, clarithromycin and rokitamycin on nifedipine metabolism in rats. Biol Pharm Bull 20: 411-416, 1997.","DOI":"10.1248\/bpb.20.411"},{"key":"4","doi-asserted-by":"publisher","unstructured":"4. Saad AH, DePestel DD, Carver PL. Factors influencing the magnitude and clinical significance of drug interactions between azole antifungals and select immunosuppressants. Pharmacotherapy 26: 1730-1744, 2006.","DOI":"10.1592\/phco.26.12.1730"},{"key":"5","doi-asserted-by":"publisher","unstructured":"5. Gandhi S, Fleet JL, Bailey DG, et al. Calcium-channel blocker-clarithromycin drug interactions and acute kidney injury. JAMA 310: 2544-2553, 2013.","DOI":"10.1001\/jama.2013.282426"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Kato J, Mori T, Nakamura Y, et al. Hypotension due to the drug interaction of voriconazole with eplerenone and nifedipine. Eur J Clin Pharmacol 65: 323-324, 2009.","DOI":"10.1007\/s00228-008-0588-1"},{"key":"7","unstructured":"7. Yang R, Luo Z, Liu Y, et al. Drug interactions with angiotensin receptor blockers: role of human cytochromes P450. Curr Drug Metab 17: 681-691, 2016."},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Peyriere H, Eiden C, Macia JC, et al. Antihypertensive drugs in patients treated with antiretrovirals. Ann Pharmacother 46: 703-709, 2012.","DOI":"10.1345\/aph.1Q546"},{"key":"9","unstructured":"9. Interview Form (product information booklet) of Adalat-CR<sup>\u00ae<\/sup> Tablets. Bayer Yakuhin, Ltd., Osaka, Japan, 2013.."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Baranda AB, Alonso RM, Jimenez RM, Weinmann W. Instability of calcium channel antagonists during sample preparation for LC-MS-MS analysis of serum samples. Forensic Sci Int 156: 23-34, 2006.","DOI":"10.1016\/j.forsciint.2004.11.014"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Cupples WA. Interactions contributing to kidney blood flow autoregulation. Curr Opin Nephrol Hypertens 16: 39-45, 2007.","DOI":"10.1097\/MNH.0b013e3280117fc7"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Abuelo JG. Normotensive ischemic acute renal failure. N Engl J Med 357: 797-805, 2007.","DOI":"10.1056\/NEJMra064398"},{"key":"13","unstructured":"13. Macedo E, Mehta RL. Prerenal failure: from old concepts to new paradigms. Curr Opin Crit Care 15: 467-473, 2009."},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Somchit N, Chung JH, Yaacob A, et al. Lack of hepato- and nephrotoxicity induced by antifungal drug voriconazole in laboratory rats. Drug Chem Toxicol 35: 304-309, 2012.","DOI":"10.3109\/01480545.2011.614619"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Guay DR, Patterson DR, Seipman N, et al. Overview of the tolerability profile of clarithromycin in preclinical and clinical trials. Drug Saf 8: 350-364, 1993.","DOI":"10.2165\/00002018-199308050-00003"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/56\/13\/56_56.8313\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,28]],"date-time":"2019-09-28T02:39:09Z","timestamp":1569638349000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/56\/13\/56_56.8313\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":15,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.56.8313","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}